Director, Global Transfer Pricing
BeiGene
Summary
The Director, Global Transfer Pricing is a strategic leadership role within the Global Tax organization responsible for developing, implementing, and governing the Company's global transfer pricing strategy. This position provides leadership over transfer pricing policy, value chain alignment, intercompany transactions, tax authority controversy management, and operational transfer pricing governance. The Director partners closely with Finance, Legal, Treasury, Supply Chain, Commercial, Manufacturing, R&D, and Business Development teams to ensure transfer pricing outcomes appropriately reflect the Company's global operating model, intellectual property ownership structure, and value creation activities.
Job description
General Description
The Director, Global Transfer Pricing is a strategic leadership role within the Global Tax organization responsible for developing, implementing, and governing the Company's global transfer pricing strategy. This position provides leadership over transfer pricing policy, value chain alignment, intercompany transactions, tax authority controversy management, and operational transfer pricing governance. The Director partners closely with Finance, Legal, Treasury, Supply Chain, Commercial, Manufacturing, R&D, and Business Development teams to ensure transfer pricing outcomes appropriately reflect the Company's global operating model, intellectual property ownership structure, and value creation activities.
Essential Functions of the Job
- Develop and maintain the Company's global transfer pricing framework, policies, and governance standards.
- Ensure alignment between transfer pricing outcomes and business operations, value creation, intellectual property ownership, and economic substance.
- Oversee implementation and execution of global transfer pricing policies across all jurisdictions.
- Lead preparation of Master Files, Local Files, Country-by-Country Reporting support, benchmarking studies, and audit-ready documentation.
- Provide transfer pricing leadership for acquisitions, licensing arrangements, collaborations, joint ventures, and other strategic transactions.
- Lead transfer pricing audit defense and controversy management activities globally.
- Drive automation, process enhancement, and digital transformation initiatives related to transfer pricing operations.
- Lead APA strategy, negotiations, implementation and compliance activities.
- Manage MAP and competent authority proceedings where appropriate.
Technology & Transformation
- Drive SAP-enabled transfer pricing process improvements.
- Lead tax technology and automation initiatives.
- Leverage AI and analytics to improve controls and operational efficiency.
Leadership & Stakeholder Management
- Ability to work on a matrix environment and supervise a broad external advisor network.
- Partner with Treasury, Legal, Supply Chain, R&D, Manufacturing and Commercial teams.
Qualifications
- 12+ years of transfer pricing experience in a multinational corporation and/or Big Four advisory environment.
- Bachelor's degree in Accounting, Finance, Economics, or related field required. Advanced degree (Master's in Taxation, Economics, Accounting, or MBA) preferred.
- Deep expertise in OECD Transfer Pricing Guidelines, BEPS initiatives, benchmarking studies and global documentation requirements.
- Significant experience with intellectual property, licensing, manufacturing, distribution, services, and financing transactions.
- Extensive experience using SAP (including S/4HANA environments) to support transfer pricing execution and reporting.
- Demonstrated experience automating transfer pricing calculations and intercompany entries.
- Proven experience negotiating and managing APAs and supporting MAP proceedings.
- Experience defending transfer pricing positions in audits across multiple jurisdictions.
Preferred Qualifications
- Pharmaceutical, biotechnology or life sciences industry experience.
- Experience leading global transfer pricing transformations.
- Experience supporting Pillar Two implementation.
- Experience managing global transfer pricing models.
Critical Leadership Competencies
- Strategic Transfer Pricing Leadership
- Executive Presence and Communication
- Transfer Pricing Audit and Controversy Management
- Technology and Automation Leadership
- Cross-Functional Collaboration
- Risk Management and Governance
Requirements
- 12+ years of transfer pricing experience in a multinational corporation and/or Big Four advisory environment.
- Bachelor's degree in Accounting, Finance, Economics, or related field required.
- Deep expertise in OECD Transfer Pricing Guidelines, BEPS initiatives, benchmarking studies and global documentation requirements.
- Significant experience with intellectual property, licensing, manufacturing, distribution, services, and financing transactions.
- Extensive experience using SAP (including S/4HANA environments) to support transfer pricing execution and reporting.
- Demonstrated experience automating transfer pricing calculations and intercompany entries.
- Proven experience negotiating and managing APAs and supporting MAP proceedings.
- Experience defending transfer pricing positions in audits across multiple jurisdictions.
- Advanced degree (Master's in Taxation, Economics, Accounting, or MBA) preferred.
- Pharmaceutical, biotechnology or life sciences industry experience preferred.
- Experience leading global transfer pricing transformations preferred.
- Experience supporting Pillar Two implementation preferred.
- Experience managing global transfer pricing models preferred.
Benefits
- Medical, Dental & Vision
- 401(k)
- FSA/HSA
- Life Insurance
- Paid Time Off
- Wellness
- Annual Bonus Plan
- Incentive Compensation Plan
- Stock Ownership
- Employee Stock Purchase Plan
Company overview
BeiGene, Ltd., now rebranding as BeOne Medicines, is a global commercial-stage biotechnology company specializing in the discovery, development, manufacturing, and commercialization of innovative oncology medicines. Founded in 2010 by John V. Oyler and Xiaodong Wang, the company has grown into a multinational organization with headquarters in Cambridge, Massachusetts, Beijing, China, and Basel, Switzerland. BeiGene focuses on developing targeted and immune-oncology therapies for cancer treatment, with a diverse pipeline that includes internally discovered products like BRUKINSA (zanubrutinib), a Bruton's tyrosine kinase inhibitor, and Tevimbra (tislelizumab), a PD-1 inhibitor. The company operates across six continents with over 45 countries participating in clinical trials and has enrolled more than 30,000 patients in its research programs. With approximately 12,000 employees worldwide, BeiGene has established itself as a significant player in global oncology, particularly with strong market presence in China and expanding operations in the United States and Europe. The company's mission centers on expanding access to high-quality cancer therapies worldwide through persistent innovation and challenging traditional approaches to drug development.